1 paper
Ethan M. Alt, Yixiang Qu, Emily Damone +3
In oncology clinical trials, tumor burden (TB) stands as a crucial longitudinal biomarker, reflecting the toll a tumor takes on a patient's prognosis. With certain treatments, the…